NASDAQ:BNBX Applied Dna Sciences (BNBX) Stock Price, News & Analysis $0.14 0.00 (0.00%) As of 01:33 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsSEC Filings About Applied Dna Sciences Stock (NASDAQ:BNBX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Applied Dna Sciences alerts:Sign Up Key Stats Today's Range$0.14▼$0.1550-Day Range$0.08▼$0.1752-Week Range$0.07▼$7.15Volume31,534 shsAverage Volume416,475 shsMarket Capitalization$842.79 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview Applied DNA Sciences, Inc. is a biotechnology company that develops and commercializes DNA-based technologies for molecular diagnostics, biopharmaceutical manufacturing and supply-chain security. Its platform uses synthetic and naturally occurring DNA sequences as tools for identification, authentication, traceability and biological production. The company’s offerings have included the CertainT platform for textile and supply-chain traceability, SigNature molecular tags for product authentication and anti-counterfeiting, and DNA-based solutions used in life sciences research and manufacturing. Applied DNA has also developed molecular diagnostic products and technologies intended to support pathogen detection and other clinical applications. Founded in 2002 and headquartered in Stony Brook, New York, Applied DNA Sciences serves customers in the United States and international markets through applications spanning textiles, consumer products, industrial materials, agriculture and healthcare. The company has historically been led by founder James A. Hayward, who has served as chairman and chief executive officer.AI Generated. May Contain Errors. Read More Applied Dna Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks1st Percentile Overall ScoreBNBX MarketRank™: Applied Dna Sciences scored higher than 1% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.5 / 5Analyst RatingSell Consensus RatingApplied Dna Sciences has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageApplied Dna Sciences has received no research coverage in the past 90 days.Read more about Applied Dna Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Applied Dna Sciences is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Applied Dna Sciences is -0.04, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioApplied Dna Sciences has a P/B Ratio of 0.09. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for BNBX. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldApplied Dna Sciences does not currently pay a dividend.Dividend GrowthApplied Dna Sciences does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Applied Dna Sciences this week, compared to 1 article on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Applied Dna Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders6.14% of the stock of Applied Dna Sciences is held by insiders.Percentage Held by Institutions22.22% of the stock of Applied Dna Sciences is held by institutions.Read more about Applied Dna Sciences' insider trading history. Receive BNBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Applied Dna Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BNBX Stock News HeadlinesReviewing Applied Dna Sciences (BNBX) & Its CompetitorsSeptember 21 at 5:28 AM | americanbankingnews.comBNB Plus Corp. Appoints Three New Directors Identified Through Ongoing Strategic ReviewSeptember 3, 2026 | businesswire.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.September 23 at 1:00 AM | Profits Run (Ad)BNB Plus Corp. (BNBX) Announces Nasdaq Delisting Determination and Transition to OTCQB Market; Company to Seek Review by Nasdaq Listing and Hearing Review CouncilJuly 13, 2026 | businesswire.comBNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder ValueApril 20, 2026 | businesswire.comSee More Headlines BNBX Stock Analysis - Frequently Asked Questions How have BNBX shares performed this year? Applied Dna Sciences' stock was trading at $1.51 on January 27, 2026. Since then, BNBX stock has decreased by 91.0% and is now trading at $0.1360. How were Applied Dna Sciences' earnings last quarter? Applied Dna Sciences Inc (NASDAQ:BNBX) released its earnings results on Thursday, August, 13th. The company reported ($0.57) earnings per share for the quarter. The firm had revenue of $0.61 million for the quarter. Applied Dna Sciences had a negative trailing twelve-month return on equity of 349.95% and a negative net margin of 1,647.25%. How do I buy shares of Applied Dna Sciences? Shares of BNBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/13/2026Today9/23/2026Fiscal Year End9/30/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (9m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 BNBX's financial health is in the Yellow zone, according to TradeSmith. BNBX has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:BNBX CIK744452 Webadnas.com Phone(631) 240-8800Fax631-240-8900Employees70Year Founded1983Profitability EPS (Trailing Twelve Months)($3.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$15.16 million Net Margins-1,647.25% Pretax Margin-1,671.00% Return on Equity-349.95% Return on Assets-283.96% Debt Debt-to-Equity RatioN/A Current Ratio1.82 Quick Ratio1.74 Sales & Book Value Annual Sales$2.09 million Price / Sales0.40 Cash FlowN/A Price / Cash FlowN/A Book Value$1.50 per share Price / Book0.09Miscellaneous Outstanding Shares6,197,000Free Float6,755,000Market Cap$842.79 thousand OptionableN/A Beta0.63 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:BNBX) was last updated on 9/23/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Dna Sciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Dna Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNBX Stock Alerts